Back to LLY
KBC Group NV LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
15
Latest value
$10.5M
Q3 2026
Peak value
$689.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $41.2M |
| Q3 2025 | $480.1M |
| Q3 2025 | $6.6M |
| Q4 2025 | $58M |
| Q4 2025 | $689.3M |
| Q4 2025 | $9.3M |
| Q1 2026 | $41.4M |
| Q1 2026 | $481.5M |
| Q1 2026 | $7M |
| Q2 2026 | $39.6M |
| Q2 2026 | $605.5M |
| Q2 2026 | $8.5M |
| Q3 2026 | $38.3M |
| Q3 2026 | $676.4M |
| Q3 2026 | $10.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10.5M | 9.1K | — | — |
| Q3 2026 | $676.4M | 584.6K | — | — |
| Q3 2026 | $38.3M | 33.1K | — | — |
| Q2 2026 | $8.5M | 7.1K | — | — |
| Q2 2026 | $605.5M | 504.9K | — | — |
| Q2 2026 | $39.6M | 33.0K | — | — |
| Q1 2026 | $7M | 7.6K | — | — |
| Q1 2026 | $481.5M | 523.5K | — | — |
| Q1 2026 | $41.4M | 45.1K | — | — |
| Q4 2025 | $9.3M | 8.7K | — | — |
| Q4 2025 | $689.3M | 641.4K | — | — |
| Q4 2025 | $58M | 54.0K | — | — |
| Q3 2025 | $6.6M | 8.7K | — | — |
| Q3 2025 | $480.1M | 629.3K | — | — |
| Q3 2025 | $41.2M | 54.0K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B